CDKN1A and breast cancer: Inaddition, Mousses at al. [18] observed that the rare alleles of these two SNPswere under-represented in breast cancer and sarcoma patients whose tumorspossessed somatic p53 mutations, as compared to tumors without p53 mutations,suggesting that these alleles could influence p21 functions in ap53-independent manner.